metaraminol has been researched along with Myocardial Ischemia in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic gas embolism during endobronchial laser treatment has been previously reported with poor outcomes and significant mortality." | 1.35 | Transient transmural ischaemia during endobronchial laser treatment: possible coronary artery embolism. ( Claydon, R; Hall, A; Haydon, TP, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haydon, TP | 1 |
| Claydon, R | 1 |
| Hall, A | 1 |
1 other study available for metaraminol and Myocardial Ischemia
| Article | Year |
|---|---|
Transient transmural ischaemia during endobronchial laser treatment: possible coronary artery embolism.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Bronchoscopy; Coro | 2008 |